BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32612100)

  • 1. Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: comparing with extracellular vesicles derived from mesenchymal stem cells.
    Gomzikova MO; Aimaletdinov AM; Bondar OV; Starostina IG; Gorshkova NV; Neustroeva OA; Kletukhina SK; Kurbangaleeva SV; Vorobev VV; Garanina EE; Persson JL; Jeyapalan J; Mongan NP; Khaiboullina SF; Rizvanov AA
    Sci Rep; 2020 Jul; 10(1):10740. PubMed ID: 32612100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic Activity of Cytochalasin B-Induced Membrane Vesicles of Human Mesenchymal Stem Cells.
    Gomzikova MO; Zhuravleva MN; Vorobev VV; Salafutdinov II; Laikov AV; Kletukhina SK; Martynova EV; Tazetdinova LG; Ntekim AI; Khaiboullina SF; Rizvanov AA
    Cells; 2019 Dec; 9(1):. PubMed ID: 31906012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cell Derived Biocompatible Membrane Vesicles Demonstrate Immunomodulatory Activity Inhibiting Activation and proliferation of Human Mononuclear Cells.
    Gomzikova MO; Kletukhina SK; Kurbangaleeva SV; Neustroeva OA; Vasileva OS; Garanina EE; Khaiboullina SF; Rizvanov AA
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32585863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-β1 can kill carcinoma cancer cells.
    Chulpanova DS; Gilazieva ZE; Akhmetzyanova ER; Kletukhina SK; Rizvanov AA; Solovyeva VV
    Tissue Cell; 2021 Dec; 73():101664. PubMed ID: 34678531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Interaction of Human Neuroblastoma Cell-Derived Cytochalasin B Induced Membrane Vesicles with Mesenchymal Stem Cells Using Imaging Flow Cytometry.
    Solovyeva VV; Kitaeva KV; Chulpanova DS; Arkhipova SS; Filin IY; Rizvanov AA
    Bionanoscience; 2022; 12(2):293-301. PubMed ID: 35261871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Storage stability and delivery potential of cytochalasin B induced membrane vesicles.
    Kletukhina SK; Neustroeva OA; Kurbangaleeva SV; Salafutdinov II; Rogov AM; James V; Rizvanov AA; Gomzikova MO
    Biotechnol Rep (Amst); 2021 Jun; 30():e00616. PubMed ID: 33996522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Cytochalasin B-Induced Membrane Vesicles Fusion Specificity with Target Cells.
    Gomzikova M; Kletukhina S; Kurbangaleeva S; Rizvanov A
    Biomed Res Int; 2018; 2018():7053623. PubMed ID: 29850552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochalasin B-Induced Membrane Vesicles from Human Mesenchymal Stem Cells Overexpressing IL2 Are Able to Stimulate CD8
    Chulpanova DS; Gilazieva ZE; Kletukhina SK; Aimaletdinov AM; Garanina EE; James V; Rizvanov AA; Solovyeva VV
    Biology (Basel); 2021 Feb; 10(2):. PubMed ID: 33579033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles.
    Gómez-Ferrer M; Villanueva-Badenas E; Sánchez-Sánchez R; Sánchez-López CM; Baquero MC; Sepúlveda P; Dorronsoro A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death.
    Stone ML; Zhao Y; Robert Smith J; Weiss ML; Kron IL; Laubach VE; Sharma AK
    Respir Res; 2017 Dec; 18(1):212. PubMed ID: 29268735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis.
    Zheng G; Huang R; Qiu G; Ge M; Wang J; Shu Q; Xu J
    Cell Tissue Res; 2018 Oct; 374(1):1-15. PubMed ID: 29955951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stromal Cells and Their Extracellular Vesicles Enhance the Anti-Inflammatory Phenotype of Regulatory Macrophages by Downregulating the Production of Interleukin (IL)-23 and IL-22.
    Hyvärinen K; Holopainen M; Skirdenko V; Ruhanen H; Lehenkari P; Korhonen M; Käkelä R; Laitinen S; Kerkelä E
    Front Immunol; 2018; 9():771. PubMed ID: 29706969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Yield of Extracellular Vesicles after Cytochalasin B Treatment and Vortexing.
    Kurbangaleeva SV; Syromiatnikova VY; Prokopeva AE; Rogov AM; Khannanov AA; Rizvanov AA; Gomzikova MO
    Curr Issues Mol Biol; 2023 Mar; 45(3):2431-2443. PubMed ID: 36975528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.
    Kim S; Maeng JY; Hyun SJ; Sohn HJ; Kim SY; Hong CH; Kim TG
    Theranostics; 2020; 10(11):5011-5028. PubMed ID: 32308765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization.
    Cao L; Xu H; Wang G; Liu M; Tian D; Yuan Z
    Int Immunopharmacol; 2019 Jul; 72():264-274. PubMed ID: 31005036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles from mesenchymal stem cells prevent contact hypersensitivity through the suppression of Tc1 and Th1 cells and expansion of regulatory T cells.
    Guo L; Lai P; Wang Y; Huang T; Chen X; Luo C; Geng S; Huang X; Wu S; Ling W; Huang L; Du X; Weng J
    Int Immunopharmacol; 2019 Sep; 74():105663. PubMed ID: 31200338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease
    Hackel A; Vollmer S; Bruderek K; Lang S; Brandau S
    Front Immunol; 2023; 14():1078551. PubMed ID: 36875112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells as a New Protective Strategy in Osteoarthritic Chondrocytes.
    Tofiño-Vian M; Guillén MI; Pérez Del Caz MD; Silvestre A; Alcaraz MJ
    Cell Physiol Biochem; 2018; 47(1):11-25. PubMed ID: 29763932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of microvesicles from mesenchymal stem cells.
    Mohammadi MR; Riazifar M; Pone EJ; Yeri A; Van Keuren-Jensen K; Lässer C; Lotvall J; Zhao W
    Methods; 2020 May; 177():50-57. PubMed ID: 31669353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.